HOME >> BIOLOGY >> NEWS
Researchers discover novel form of the Rett Syndrome protein

March 21, 2004 Research spearheaded by investigators from The Hospital for Sick Children and the University of Toronto has uncovered a new form of the protein MeCP2 that is ten times more prevalent in adult human brain then the originally described form. The findings will be reported in the April issue of the scientific journal Nature Genetics (available online March 21, 2004).

In 1999 Huda Zoghbi of Baylor College of Medicine identified mutations in the MECP2 gene as the leading cause of Rett Syndrome (RTT). The MECP2 gene can be envisioned as a book with four chapters, called exons. By splicing these exons into different configurations genes can make alternate forms of a protein. The novel form of the MeCP2 protein shares exons three and four with the original form but is missing exon two. Furthermore, the Canadian researchers report the first identified mutations in exon one.

Berge Minassian, the lead author from The Hospital for Sick Children, states, "The human genome has been sequenced completely, yet to our ongoing amazement, the genetic information that defines who we are is much more complex than the mere DNA sequence. We are finding that many, if not most genes shuffle their sequences around to create various proteins with unique functions. We have discovered a new form of the MeCP2 protein which may turn out to be the more important form in RTT. This opens a whole new avenue of RTT research. One day, this and other similar paths will lead us to a full understanding, and hopefully a treatment for this devastating disorder."

RTT is a severe neurological disorder diagnosed almost exclusively in girls. Children with RTT appear to develop normally until 6 to 18 months of age, when they enter a period of regression, losing speech and motor skills. Most develop repetitive hand movements, irregular breathing patterns, seizures and extreme motor control problems. RTT leaves its victims profoundly disabled, requiring maximum assistan
'"/>

Contact: Monica Coenraads
monica@rsrf.org
203-445-9233
Rett Syndrome Research Foundation
21-Mar-2004


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 17, 2019 , ... Georgia ... pediatric urologists are among the professionals honored in U.S. News & World ... the country’s pediatric healthcare landscape. , Georgia Urology’s wholly-owned subsidiary, Georgia ...
(Date:7/10/2019)... ... 10, 2019 , ... Inference Solutions , a global ... announced its role in Pizza Hut Australia’s digital transformation initiative to ... key part of this initiative is implementation of an automated call-steering application that ...
(Date:6/27/2019)... ... ... Lighting designers from integrated design firm LPA recently earned two ... both engaging and energy efficient lighting systems. , The lighting for the repositioning of ... California earned an IES Illumination Award of Merit in the Energy and Environment category. ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named ... as the 2019 Innovative Product of the Year which highlights cutting-edge advancements and ... Sensors Expo & Conference 2019, held this week in San Jose, ...
(Date:6/18/2019)... YORK and SOMERSET, N.J. (PRWEB) , ... June ... ... Catalent Biologics, today announced that they have entered into an agreement for production ... product candidates, IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) ...
(Date:6/11/2019)... ... 2019 , ... Thought Technology Ltd is pleased to announce ... Tech Ltd as its authorised distributor for the UK and Ireland. , ... and clinical assessment protocols to treat stress related disorders as well as provide ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Carilion Clinic, a national leader in opioid treatment, announced today they are partnering ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic ...
Breaking Biology Technology:
Cached News: